ABEONA THERAPEUTICS INC. Derivative Liability, Noncurrent
ABEONA THERAPEUTICS INC. (ABEO) had Derivative Liability, Noncurrent of $668.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2024-08-12
- 2024-06-30: Derivative Liability, Noncurrent $668.00K.
- 2024-03-31: Derivative Liability, Noncurrent $1.00M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2024-06-30 | $668.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |